Priser
Platform
Blog
Om os
Download
7521
Musashi Co
Tokyo Stock Exchange
0

Om

Harel Insurance Investments & Financial Services Ltd. is a key player in the insurance and financial services sector in Israel. It provides a comprehensive range of insurance products, including life, health, and property insurance, tailored to meet the diverse needs of individual and corporate clients. Apart from insurance, Harel offers investment services, asset management, and pension funds, catering to both institutional and private clients. With its vast network, Harel plays a significant role in Israel’s financial market, contributing to the stability and growth of the insurance industry. The company's strategic investments in technology and customer service have enhanced its reputation as a reliable provider, while its diverse product offerings and innovative solutions ensure it remains competitive in an ever-evolving financial landscape. Founded in 1935, Harel combines traditional values with modern practices, making it a cornerstone of Israel's financial services infrastructure.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MUSASHI CO MED ENDAVU: Køb Musashi Co ($7521) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Musashi Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerHARL
Land
Israel
Antal medarbejdere5.000
Hjemmesideharel-group.co.il
SektorFinans
IndustriForsikring - Diversificeret

Udbytter

1,67ILS
'21
1,41ILS
'22
0,47ILS
'23
3,88ILS
'24
1,94ILS
'25
2,58ILS
'26
Ex-udbytte-dato9. apr. 2026
Udbytteafkast2,27%

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%